CA1340452C - Nouveaux inhibiteurs de la hmg-coa reductase - Google Patents

Nouveaux inhibiteurs de la hmg-coa reductase

Info

Publication number
CA1340452C
CA1340452C CA000617106A CA617106A CA1340452C CA 1340452 C CA1340452 C CA 1340452C CA 000617106 A CA000617106 A CA 000617106A CA 617106 A CA617106 A CA 617106A CA 1340452 C CA1340452 C CA 1340452C
Authority
CA
Canada
Prior art keywords
pharmaceutically acceptable
acceptable salt
compound
formula
pyran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000617106A
Other languages
English (en)
Inventor
Edward S. Inamine
David R. Houck
Otto D. Hensens
Wasyl Halczenko
George D. Hartman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CA000540097A external-priority patent/CA1340331C/fr
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to CA000617106A priority Critical patent/CA1340452C/fr
Application granted granted Critical
Publication of CA1340452C publication Critical patent/CA1340452C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
CA000617106A 1986-06-23 1998-10-13 Nouveaux inhibiteurs de la hmg-coa reductase Expired - Fee Related CA1340452C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000617106A CA1340452C (fr) 1986-06-23 1998-10-13 Nouveaux inhibiteurs de la hmg-coa reductase

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US87704186A 1986-06-23 1986-06-23
US193387A 1987-01-09 1987-01-09
US4813687A 1987-05-15 1987-05-15
CA000540097A CA1340331C (fr) 1986-06-23 1987-06-19 Inhibiteurs de la reductase hmg-coa
CA000617106A CA1340452C (fr) 1986-06-23 1998-10-13 Nouveaux inhibiteurs de la hmg-coa reductase

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA000540097A Division CA1340331C (fr) 1986-06-23 1987-06-19 Inhibiteurs de la reductase hmg-coa

Publications (1)

Publication Number Publication Date
CA1340452C true CA1340452C (fr) 1999-03-16

Family

ID=27426482

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000617106A Expired - Fee Related CA1340452C (fr) 1986-06-23 1998-10-13 Nouveaux inhibiteurs de la hmg-coa reductase

Country Status (1)

Country Link
CA (1) CA1340452C (fr)

Similar Documents

Publication Publication Date Title
CA1340331C (fr) Inhibiteurs de la reductase hmg-coa
US4940727A (en) Novel HMG-CoA reductase inhibitors
US4294926A (en) Hypocholesteremic fermentation products and process of preparation
US4231938A (en) Hypocholesteremic fermentation products and process of preparation
US4319039A (en) Preparation of ammonium salt of hypocholesteremic fermentation product
US4294846A (en) Hypocholesteremic fermentation products and products of preparation
US5116870A (en) HMG-CoA reductase inhibitors
EP0022478B1 (fr) Polyhydro-3,7-diméthyl-8-(2-(tétrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)-éthyl)-1-naphtylényl-2-méthylbutanoates, les hydroxy-acides correspondants, procédé de préparation et compositions pharmaceutiques les contenant
EP0331250B1 (fr) Agents antihypercholestérolémiques
US4342767A (en) Hypocholesteremic fermentation products
US5021453A (en) 3-keto HMG-CoA reductase inhibitors
US4420491A (en) Hypocholesteremic fermentation products and process of preparation
SE468482B (sv) Framstaellning av monakolin k
US4965200A (en) Process for the preparation of 3-keto, 5-hydroxy simvastatin analogs
USRE36481E (en) HMG-CoA reductase inhibitors
US4997849A (en) Microbial transformation of simvastatin
US4997755A (en) HMG-CoA reductase inhibitors produced by Nocardia sp. (MA 6455)
EP0408806A1 (fr) Agents antihypercholestérolémiques
JPH02245191A (ja) ６―α―ヒドロキシメチルロバスタチン誘導体の製造方法
US5041562A (en) 3-keto HMG-CoA reductase inhibitors
JP2582785B2 (ja) 新規ＨＭＧ−ＣｏＡレダクタ−ゼ阻害剤
JPH0354103B2 (fr)
EP0409399B1 (fr) Inhibiteurs de 3-céto HMG-CoA réductase
JPH0333698B2 (fr)
AU618106B2 (en) 3-keto-naphtylethyl substituted pyran-2-ones and equilavent hydroxy acids

Legal Events

Date Code Title Description
MKLA Lapsed